Rankings
▼
Calendar
LTRN FY 2018 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena
LTRN
Lantern Pharma Inc.
$30M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$2,544
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-0.28
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$185,604
Balance Sheet
Total Assets
$449,831
Total Liabilities
$651,629
Stockholders' Equity
-$201,798
Cash & Equivalents
$445,163
← Q1 2019
All Quarters